{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:08:11Z","timestamp":1773274091385,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s40121-025-01191-6","type":"journal-article","created":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T08:40:10Z","timestamp":1751704810000},"page":"1997-2006","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Impact of Continuous Renal Replacement Therapy with Polyacrylonitrile-Derived Filter on Caspofungin Concentration: A Retrospective Study"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6779-5368","authenticated-orcid":false,"given":"Romain","family":"Arrestier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0728-2701","authenticated-orcid":false,"given":"Claire","family":"Pressiat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Bouabdallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5817-2257","authenticated-orcid":false,"given":"Paul","family":"Masi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2756-4052","authenticated-orcid":false,"given":"Nicolas","family":"Mongardon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9430-9866","authenticated-orcid":false,"given":"Anne","family":"Hulin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5961-5577","authenticated-orcid":false,"given":"Armand","family":"Mekontso Dessap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7979-2650","authenticated-orcid":false,"given":"Keyvan","family":"Razazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,5]]},"reference":[{"key":"1191_CR1","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ933","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases Society of America. Clin Infect Dis. 2016;62:e1-50.","journal-title":"Clin Infect Dis"},{"key":"1191_CR2","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1128\/AAC.48.3.815-823.2004","volume":"48","author":"JA Stone","year":"2004","unstructured":"Stone JA, Xu X, Winchell GA, Deutsch PJ, Pearson PG, Migoya EM, et al. Disposition of caspofungin: role of distribution in determining pharmacokinetics in plasma. Antimicrob Agents Chemother. 2004;48:815\u201323.","journal-title":"Antimicrob Agents Chemother"},{"key":"1191_CR3","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01582-16","author":"KCM van der Elst","year":"2017","unstructured":"van der Elst KCM, Veringa A, Zijlstra JG, Beishuizen A, Klont R, Brummelhuis-Visser P, et al. Low caspofungin exposure in patients in intensive care units. Antimicrob Agents Chemother. 2017. https:\/\/doi.org\/10.1128\/aac.01582-16.","journal-title":"Antimicrob Agents Chemother"},{"key":"1191_CR4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1093\/jac\/dkm125","volume":"60","author":"TH Nguyen","year":"2007","unstructured":"Nguyen TH, Hoppe-Tichy T, Geiss HK, Rastall AC, Swoboda S, Schmidt J, et al. Factors influencing caspofungin plasma concentrations in patients of a surgical intensive care unit. J Antimicrob Chemother. 2007;60:100\u20136.","journal-title":"J Antimicrob Chemother"},{"key":"1191_CR5","doi-asserted-by":"publisher","first-page":"e01545","DOI":"10.1128\/AAC.01545-20","volume":"64","author":"S Bailly","year":"2020","unstructured":"Bailly S, Gautier-Veyret E, L\u00ea MP, Bouadma L, Andremont O, Neuville M, et al. Impact of loading dose of caspofungin in pharmacokinetic-pharmacodynamic target attainment for severe candidiasis infections in patients in intensive care units: the CASPOLOAD study. Antimicrob Agents Chemother. 2020;64:e01545-e1620.","journal-title":"Antimicrob Agents Chemother"},{"key":"1191_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13054-015-0758-3","volume":"19","author":"MG Sinnollareddy","year":"2015","unstructured":"Sinnollareddy MG, Roberts JA, Lipman J, Akova M, Bassetti M, De Waele JJ, et al. Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study. Crit Care. 2015;19:33.","journal-title":"Crit Care"},{"key":"1191_CR7","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s40262-016-0495-z","volume":"56","author":"C Roger","year":"2017","unstructured":"Roger C, Wallis SC, Muller L, Saissi G, Lipman J, Br\u00fcggemann RJ, et al. Caspofungin population pharmacokinetics in critically ill patients undergoing continuous veno-venous haemofiltration or haemodiafiltration. Clin Pharmacokinet. 2017;56:1057\u201368.","journal-title":"Clin Pharmacokinet"},{"key":"1191_CR8","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1128\/AAC.00335-13","volume":"57","author":"S Weiler","year":"2013","unstructured":"Weiler S, Seger C, Pfisterer H, Stienecke E, Stippler F, Welte R, et al. Pharmacokinetics of caspofungin in critically ill patients on continuous renal replacement therapy. Antimicrob Agents Chemother. 2013;57:4053\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"1191_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13054-016-1594-9","volume":"21","author":"G Aguilar","year":"2017","unstructured":"Aguilar G, Ferriols R, Lozano A, Ezquer C, Carbonell JA, Jurado A, et al. Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients. Crit Care. 2017;21:17.","journal-title":"Crit Care"},{"key":"1191_CR10","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1093\/jac\/dkq081","volume":"65","author":"MW Pound","year":"2010","unstructured":"Pound MW, Townsend ML, Drew RH. Echinocandin pharmacodynamics: review and clinical implications. J Antimicrob Chemother. 2010;65:1108\u201318.","journal-title":"J Antimicrob Chemother"},{"key":"1191_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.107007","volume":"62","author":"FJ Baud","year":"2023","unstructured":"Baud FJ, Jullien V, Desnos-Ollivier M, Lamhaut L, Lortholary O. Caspofungin sequestration in a polyacrylonitrile-derived filter: increasing the dose does not mitigate sequestration. Int J Antimicrob Agents. 2023;62: 107007.","journal-title":"Int J Antimicrob Agents"},{"key":"1191_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.accpm.2020.01.007","volume":"40","author":"FJ Baud","year":"2021","unstructured":"Baud FJ, Jullien V, Secr\u00e9tan P-H, Houz\u00e9 P, Lamhaut L. Are we correctly treating invasive candidiasis under continuous renal replacement therapy with echinocandins? Preliminary in vitro assessment. Anaesthesia Crit Care Pain Med. 2021;40: 100640.","journal-title":"Anaesthesia Crit Care Pain Med"},{"key":"1191_CR13","unstructured":"Information de s\u00e9curit\u00e9 \u2013 Caspofungine\u202f: l\u2019ANSM recommande de n [Internet]. ANSM. [cited 2024 Nov 27]. Available from: https:\/\/ansm.sante.fr\/informations-de-securite\/caspofungine-lansm-recommande-de-ne-pas-utiliser-de-membrane-derivee-du-polyacrylonitrile-chez-les-patients-en-soins-intensifs-sous-hemofiltration"},{"key":"1191_CR14","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10096-019-03477-3","volume":"38","author":"C Agnelli","year":"2019","unstructured":"Agnelli C, Valerio M, Bouza E, Vena A, Guinea J, del Carmen M-J, et al. Persistent Candidemia in adults: underlying causes and clinical significance in the antifungal stewardship era. Eur J Clin Microbiol Infect Dis. 2019;38:607\u201314.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1191_CR15","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02466-18","author":"S Kurland","year":"2019","unstructured":"Kurland S, Furebring M, L\u00f6wdin E, Eliasson E, Nielsen EI, Sj\u00f6lin J. Pharmacokinetics of caspofungin in critically ill patients in relation to liver dysfunction: differential impact of plasma albumin and bilirubin levels. Antimicrob Agents Chemother. 2019. https:\/\/doi.org\/10.1128\/aac.02466-18.","journal-title":"Antimicrob Agents Chemother"},{"key":"1191_CR16","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1177\/03913988211032236","volume":"44","author":"FJ Baud","year":"2021","unstructured":"Baud FJ, Seif V, Houz\u00e9 P, Raphalen J-H, Pilmis B, Carli P, et al. Elimination of three doses of gentamicin over three consecutive days using a polyacrylonitrile-derived filter: an in vitro assessment. Int J Artif Organs. 2021;44:641\u201350.","journal-title":"Int J Artif Organs"},{"key":"1191_CR17","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/aor.12982","volume":"42","author":"P Kolbinger","year":"2018","unstructured":"Kolbinger P, Gruber M, Roth G, Graf BM, Ittner K-P. Filter adsorption of anidulafungin to a polysulfone-based hemofilter during CVVHD in vitro. Artif Organs. 2018;42:200\u20137.","journal-title":"Artif Organs"},{"key":"1191_CR18","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1093\/jac\/dku313","volume":"69","author":"EW Muilwijk","year":"2014","unstructured":"Muilwijk EW, Schouten JA, van Leeuwen HJ, van Zanten ARH, de Lange DW, Colbers A, et al. Pharmacokinetics of caspofungin in ICU patients. J Antimicrob Chemother. 2014;69:3294\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"1191_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.107078","volume":"63","author":"A Jendoubi","year":"2024","unstructured":"Jendoubi A, Pressiat C, De Roux Q, Hulin A, Ghaleh B, Tissier R, et al. The impact of extracorporeal membrane oxygenation on antifungal pharmacokinetics: a systematic review. Int J Antimicrob Agents. 2024;63: 107078.","journal-title":"Int J Antimicrob Agents"},{"key":"1191_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/myc.13386","volume":"65","author":"S Kurland","year":"2022","unstructured":"Kurland S, L\u00f6wdin E, Furebring M, Shams A, Chryssanthou E, Lagerb\u00e4ck P, et al. Human plasma protein levels alter the in vitro antifungal activity of caspofungin: an explanation to the effect in critically ill? Mycoses. 2022;65:79\u201387.","journal-title":"Mycoses"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-025-01191-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-025-01191-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-025-01191-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T00:54:04Z","timestamp":1757206444000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-025-01191-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,5]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1191"],"URL":"https:\/\/doi.org\/10.1007\/s40121-025-01191-6","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,5]]},"assertion":[{"value":"19 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Romain Arrestier reports personal fees from Pharma Dom, MSD and Baxter outside the submitted work. Armand Mekontso Dessap reports grants from Fisher&Paykel, Baxter, Philips, Ferring and GSK, personal fees from Air Liquide, Baxter, Amomed, Getinge and Addmedica, outside the submitted work. Keyvan Razazi received lecture fees from MSD, Shionogi, and a travel grant from Pfizer outside the submitted work. Nicolas Mongardon received personal fees from AOP Health and Baxter, and research grants from Air Liquide outside the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The French Intensive Care Society Ethics Committee approved the study (CE SRLF n\u00b0 24\u2013093, IRB n\u00b0 00014135), and written informed consent was waived per French regulations. The study was performed in accordance with the Helsinki Declarations and all its amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}